161 related articles for article (PubMed ID: 31959052)
1. Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients.
Ognibene M; Morini M; Garaventa A; Podestà M; Pezzolo A
Cancer Biol Ther; 2020 May; 21(5):391-399. PubMed ID: 31959052
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
[TBL] [Abstract][Full Text] [Related]
3. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Shishikura T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Tomioka N; Sakiyama S; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Nakagawara A
Oncogene; 2000 Aug; 19(37):4302-7. PubMed ID: 10980605
[TBL] [Abstract][Full Text] [Related]
5. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
6. Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss.
Hoshi M; Otagiri N; Shiwaku HO; Asakawa S; Shimizu N; Kaneko Y; Ohi R; Hayashi Y; Horii A
Br J Cancer; 2000 Jun; 82(11):1801-7. PubMed ID: 10839294
[TBL] [Abstract][Full Text] [Related]
7. Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.
Amoroso L; Ognibene M; Morini M; Conte M; Di Cataldo A; Tondo A; D'Angelo P; Castellano A; Garaventa A; Lasorsa VA; Podestà M; Capasso M; Pezzolo A
Genes Chromosomes Cancer; 2020 May; 59(5):277-285. PubMed ID: 31756773
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum.
Huang LW; Garrett AP; Muto MG; Colitti CV; Bell DA; Welch WR; Berkowitz RS; Mok SC
Hum Pathol; 2000 Mar; 31(3):367-73. PubMed ID: 10746681
[TBL] [Abstract][Full Text] [Related]
9. Detailed molecular analysis of 1p36 in neuroblastoma.
White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
[TBL] [Abstract][Full Text] [Related]
10. Identification of exons in a region of human chromosome 6q known to contain tumour suppressor genes.
Barua U; Rousseaux S; Edwards YH
DNA Seq; 1996; 7(1):13-9. PubMed ID: 9063630
[TBL] [Abstract][Full Text] [Related]
11. Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.
Pezzolo A; Sementa AR; Lerone M; Morini M; Ognibene M; Defferrari R; Mazzocco K; Conte M; Gigliotti AR; Garaventa A; Pistoia V; Varesio L
Cancer Biol Ther; 2017 May; 18(5):285-289. PubMed ID: 28402723
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity for chromosome 14q in neuroblastoma.
Thompson PM; Seifried BA; Kyemba SK; Jensen SJ; Guo C; Maris JM; Brodeur GM; Stram DO; Seeger RC; Gerbing R; Matthay KK; Matise TC; White PS
Med Pediatr Oncol; 2001 Jan; 36(1):28-31. PubMed ID: 11464899
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 3p microsatellite allelotyping in neuroblastoma: a report on the technical hurdles.
Hoebeeck J; De Wilde B; Michels E; Combaret V; Yigit N; De Smet E; Van Roy N; Stanbridge E; Ru N; Laureys G; De Paepe A; Speleman F; Vandesompele J
Cancer Invest; 2009 Oct; 27(8):857-68. PubMed ID: 19544108
[TBL] [Abstract][Full Text] [Related]
14. Definition of a commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27.
Saito S; Sirahama S; Matsushima M; Suzuki M; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
Cancer Res; 1996 Dec; 56(24):5586-9. PubMed ID: 8971159
[TBL] [Abstract][Full Text] [Related]
15. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma.
Takita J; Yang HW; Chen YY; Hanada R; Yamamoto K; Teitz T; Kidd V; Hayashi Y
Oncogene; 2001 Jul; 20(32):4424-32. PubMed ID: 11466626
[TBL] [Abstract][Full Text] [Related]
16. PPM1D is a potential target for 17q gain in neuroblastoma.
Saito-Ohara F; Imoto I; Inoue J; Hosoi H; Nakagawara A; Sugimoto T; Inazawa J
Cancer Res; 2003 Apr; 63(8):1876-83. PubMed ID: 12702577
[TBL] [Abstract][Full Text] [Related]
17. Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11.
De Preter K; Vandesompele J; Menten B; Carr P; Fiegler H; Edsjö A; Carter NP; Yigit N; Waelput W; Van Roy N; Bader S; Påhlman S; Speleman F
BMC Genomics; 2005 Jul; 6():97. PubMed ID: 16000168
[TBL] [Abstract][Full Text] [Related]
18. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.
Krona C; Ejeskär K; Abel F; Kogner P; Bjelke J; Björk E; Sjöberg RM; Martinsson T
Oncogene; 2003 Apr; 22(15):2343-51. PubMed ID: 12700669
[TBL] [Abstract][Full Text] [Related]
19. Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.
Parodi S; Pistorio A; Erminio G; Ognibene M; Morini M; Garaventa A; Gigliotti AR; Haupt R; Frassoni F; Pezzolo A
Pediatr Blood Cancer; 2019 May; 66(5):e27635. PubMed ID: 30688024
[TBL] [Abstract][Full Text] [Related]
20. Deletion mapping of 14q32 in human neuroblastoma defines an 1,100-kb region of common allelic loss.
Hoshi M; Shiwaku HO; Hayashi Y; Kaneko Y; Horii A
Med Pediatr Oncol; 2000 Dec; 35(6):522-5. PubMed ID: 11107107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
